Disulfidptosis induced by intermittent fasting and metformin enhances the efficacy of anti-PD-1 therapy in renal cancer - PubMed
5 hours ago
- #Disulfidptosis
- #Metformin
- #Renal Cancer
- Disulfidptosis induced by intermittent fasting and metformin enhances anti-PD-1 therapy efficacy in renal cancer.
- Study involves human tissue research approved by Urology department of Zhejiang University Affiliated Forth Hospital (K2024182) and animal experiments approved by Zhejiang University Center for Animal Experiment (ZJU20241020).
- Keywords include Disulfidptosis, Metformin, PBRM1, SLC7A11, and ccRCC.
- Authors declare no competing interests.
- References include studies on clear cell renal cell carcinoma, PBRM1 deficiency, and genomic biomarkers in renal cancer.